First of all, India has the conditions and environment to manufacture generic drugs. According to Indian law, their generic drugs are legal. Hospitals in India basically don't sell drugs, and the drugs patients need are purchased directly from pharmacies. With government guarantee, the United States, as a foreign country, has no way to directly sanction non-domestic industries, so the United States really feels powerless in dealing with this issue.
Secondly, we can look at a set of statistics. India's generic drugs account for about 20% of the global market. It exports drugs to more than 200 countries, and there are nearly 3,000 generic companies. 20 17 among the seven global generic drug companies, India has two seats, so India is a well-deserved generic drug country. In a country with a strong production chain, India's generic drug production industry is deeply rooted, which is not something that the United States can uproot if it wants to uproot it. This will involve too much interest.
Finally, it is a question of history. In the 1990s, a large number of American pharmaceutical companies set up factories in India. In the 1990s, large-scale residents sustained high fever or even died around the factory of a pharmaceutical giant in the United States, and Indian hospitals were helpless. Later, after investigation, it was caused by some components in the wastewater discharged by pharmaceutical factories. Not long after, another large-scale chemical spill occurred in India, killing thousands of people. However, the source of the problem is the chemical plant in the United States. Finally, in the case of no choice, the US government opened the FDA database to India without a drug patent law. So the current situation is that India can directly use the patent application data of all pharmaceutical industries in the United States.
So on this issue, the United States has no way to directly sanction India. If you like this answer, please do. Thank you.